InvestorsHub Logo
Followers 36
Posts 1166
Boards Moderated 0
Alias Born 03/07/2013

Re: LaddyMan post# 28102

Wednesday, 07/06/2016 2:55:30 PM

Wednesday, July 06, 2016 2:55:30 PM

Post# of 118393
I believe you are right and this wording is why we won't know the extent until the dotted line is signed most likely [Note: working in a confidential manner]:

"Lilly's Open Innovation Drug Discovery Program is visionary," said Harry Lander, Ph.D., MBA, president and chief scientific officer of Regen BioPharma, Inc. "They understand the value of partnering in a confidential manner with smaller entities that may have intellectual property that aligns with their product goals.” - See more at: http://www.contractpharma.com/contents/view_breaking-news/2016-06-30/lilly-regen-biopharma-in-drug-discovery-pact#sthash.EjndhzBY.dpuf